-
Organogenesis Holding (ORGO) Tops Q4 EPS by 2c, provides guidance
-
Avista Healthcare Partners promotes three investment team members
-
BTIG Reiterates Buy Rating on Oranogenesis Holdings (ORGO)
-
Organogenesis submits biologics license application for knee arthritis treatment
-
After-hours movers: Ford Motor, PayPal, Planet Fitness and more
-
Organogenesis plans to file BLA for ReNu knee osteoarthritis treatment
-
Oranogenesis Holdings (ORGO) PT Raised to $9 at BTIG
-
Cantor Fitzgerald Reiterates Overweight Rating on Oranogenesis Holdings (ORGO)
-
Cantor Fitzgerald Reiterates Overweight Rating on Oranogenesis Holdings (ORGO)
-
Cantor Fitzgerald Reiterates Overweight Rating on Oranogenesis Holdings (ORGO)
-
Oranogenesis Holdings (ORGO) PT Raised to $9 at Cantor Fitzgerald
-
Organogenesis Holding (ORGO) Misses Q2 EPS by 5c, provides guidance
-
Organogenesis supports CMS skin substitute payment reform proposal, urges refinements
-
Cantor Fitzgerald Reiterates Overweight Rating on Oranogenesis Holdings (ORGO)
-
After-hours movers: FB Financial, MiMedx Group, Organogenesis, and more
-
Organogenesis Holding (ORGO), Smith & Nephew (SNN) & Integra LifeSciences (IART) Also Fall on CMS Publication
-
MiMedx Group (MDXG), Organogenesis (ORGO) Shares Fall After CMS Proposal to Cut Spending
-
Organogenesis Holding (ORGO) Misses Q1 EPS by 13c
-
Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer
-
Oranogenesis Holdings (ORGO) PT Raised to $6 at Cantor Fitzgerald
-
Organogenesis Holding (ORGO) Tops Q4 EPS by 5c, provides guidance
-
Oranogenesis Holdings (ORGO) PT Raised to $3.80 at Cantor Fitzgerald
-
Organogenesis Holding (ORGO) Tops Q3 EPS by 11c
-
Organogenesis Holding (ORGO) Announces $130M Preferred Stock Offering
-
Organogenesis Holding (ORGO) Misses Q2 EPS by 14c, provides guidance
-
Organogenesis Holding (ORGO) Issues ReNu Program Update

